Case Report

Ménétrier Disease in an Acquired Immunodeficiency Syndrome Patient

Authors: Kevin M. DuPrey, BA, Shameer Ahmed, MD, Yehia Yousri Mishriki, MD

Abstract

Ménétrier disease is a rare disorder of unknown etiology. An overexpression of TGF-α has been proposed to play a role in the pathophysiology. HIV-1 tat gene product has been shown to stimulate TGF-α production leading to a positive feedback autocrine loop. The case of a 41-year-old male with AIDS who presented with weight loss, abdominal pain, ascites, edema, nausea, vomiting, and diarrhea is discussed. A computed tomography (CT) scan of the abdomen showed avid enhancement of the stomach mucosa. Magnetic resonance angiography revealed gastric and small bowel distention with diffuse wall thickening. Biopsies of the stomach showed marked foveolar hyperplasia with active inflammation and gland changes consistent with Ménétrier disease.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Toubia N, Schubert ML. Ménétrier's disease. Curr Treat Options Gastroenterol 2008;11:103–108.
 
2. Ménétrier P. [Gastric polyadenomas and their relationship with cancer of the stomach.] Arch Physiol Norm Pathol (Paris) 1888;1:32–55, 236–262 [in French].
 
3. Liu C, Crawford JM. Hypertrophic Gastropathy, in Kumar V, Abbas AK, Fausto N (eds): Pathologic Basis of Disease. Philadelphia, Elsevier, 2005, ed 7, pp 820–821.
 
4. Sferra TJ, Pawel BR, Qaulman SJ, et al. Ménétrier disease of childhood: role of cytomegalovirus and transforming growth factor alpha. J Pediatr 1996;128:213–219.
 
5. Roa K, Arguillas M. Ménétrier's disease: a case report: 319. J Gastroenterol Hepatol2006;21:6:A407.
 
6. Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice.Gastroenterology 1992;103:1950–1963.
 
7. Jarnum S, Jensen KB. Plasma protein turnover (albumin, transferrin IgG, IgM) in Ménétrier's disease (giant hypertrophic gastritis): evidence of non-selective protein loss. Gut 1972;13:128–137.
 
8. Wolfsen HC, Carpenter HA, Talley NJ. Ménétrier's disease. a form of hypertrophic gastropathy or gastritis. Gastroenterology 1993;104:1310–1319.
 
9. Scharschmidt BF. The natural history of hypertrophic gastropathy (Ménétrier's disease) report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med 1977;63:644–652.
 
10. Searcy RM, Malagelada JR. Ménétrier's disease and idiopathic hypertrophic gastropathy. Ann Intern Med 1984;100:565–570.
 
11. Fieber SS, Rickert RR. Hyperplastic gastropathy. Analysis of 50 selected cases from 1955–1980.Am J Gastroenterol 1981;76:321–329.
 
12. Sundt TM, Compton CC, Malt RA. Ménétrier's disease. A trivalent gastropathy. Ann Surg1988;208:694–701.
 
13. Beauchamp RD, Barnard JA, McCutchen CM, et al. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest 1989;84:1017–1023.
 
14. Derynck R. The physiology of transforming growth factor-α. Adv Cancer Res 1992;58:27–52.
 
15. Mueller SG, Paterson AJ, Kudlow JE. Transforming growth factor-alpha in arterioles: cell surface processing of its precursor by elastases. Mol Cell Biol 1990;10:4596–4602.
 
16. Rappolee DA, Mark D, Band MJ, et al. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988;241:708–712.
 
17. Takagi H, Jhappan C, Sharp R, et al. Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor a in the stomach. J Clin Invest1992;90:1161–1167.
 
18. Nomura S, Settle SH, Leys CM, et al. Evidence for repatterning of the gastric fundic epithelium associated with Ménétrier's disease and TGF—alpha overexpression. Gastroenterology 2005;128:1292–1305.
 
19. Kovacs AA, Churchill MA, Wood D, et al. Molecular and epidemiologic evaluations of a cluster of cases of Ménétrier's disease associated with cytomegalovirus. Pediatr Infect Dis J 1993;12:1011–1014.
 
20. Bayerdorffer E, Ritter MM, Hatz R, et al. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori—is Helicobacter pylori a pathogenic factor in Ménétrier's disease? Gut1994;35:701–704.
 
21. Xiao SY, Hart J. Marked gastric foveolar hyperplasia associated with active cytomegalovirus infection. Am J Gastroenterol 2001;96:223–226.
 
22. Stolte M, Bätz CH, Eidt S. Giant fold gastritis—a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993;31:289–293.
 
23. Nabell LM, Raja RH, Sayeski PP, et al. Human immunodeficiency virus 1 tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor dependent manner. Cell Growth Differ 1994;5:87–93.
 
24. Frankel AD, Bredt DS, Pabo CO. Tat protein from human immunodeficiency virus forms a metal-linked dimmer. Science 1988;240:70–73.
 
25. Mitola S, Silvano S, Luini W, et al. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 1997;90:1365–1372.
 
26. Sanchez C, Brody F, Pucci E, et al. Laproscopic total gastrectomy for Ménétrier's disease. J Laparoendosc Adv Surg Tech 2007;17:32–35.